AI-generated summary
The authors studied a new pulsed-dye laser with a 15 mm treatment beam in 20 people with rosacea, who received four monthly treatments. Blinded reviewers rated photographs taken two months after the last treatment, and the authors report an average improvement of 53.9%, with mild side effects such as edema, erythema and bruising. The study had no control group and only 19 subjects completed it.
- Participants
- 20
- Who or what was studied
- Twenty subjects with erythemato-telangiectatic rosacea, of whom nineteen completed the study
- Limits stated in the abstract
- The abstract describes a small single-arm study with no control group and only 19 of 20 subjects completing it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.